Temasek-backed ClavystBio leads $11m seed round in Cirrus Therapeutics

Temasek-backed ClavystBio leads $11m seed round in Cirrus Therapeutics

Photo: Brands and people/ Unsplash.com

Katrina Bianca Cuaresma

03 October, 2025

Edited by: Padma Priya

Cirrus Therapeutics ClavystBio Temasek

Printed by Unregistered user on Fri, 05 Dec 2025 22:30:41 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

ClavystBio co-anchors $11.6m funding in healthtech Respiree

Venture Capital

Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D

Read more from Singapore

Digest: SC Capital invests in Japan data centre; Coda announces new leadership

Temasek-backed Fullerton scales back China private fund operations